Development of Japanese Versions of the 4‐Item Mystical Experience Questionnaire and 7‐Item Challenging Experience Questionnaire
{"INTRODUCTION:":[0],"Interest":[1],"in":[2,113,209],"therapeutic":[3],"applications":[4],"of":[5,63,82,85,101,123,150,162,176,189],"psychedelics":[6,18,114],"has":[7],"recently":[8],"resurged.":[9],"Mystical-type":[10],"and":[11,29,42,66,73,91,108,118,121,153,157,165,179,186,191,207],"challenging":[12,192],"experiences":[13,193],"that":[14],"are":[15,19],"elicited":[16],"by":[17,79],"commonly":[20],"assessed":[21],"using":[22],"the":[23,30,64,71,80,83,89,102,119,124,151,158,163,171,177],"30-item":[24],"Mystical":[25],"Experience":[26,33],"Questionnaire":[27,34],"(MEQ-30)":[28],"26-item":[31],"Challenging":[32],"(CEQ),":[35],"respectively.":[36],"The":[37,145],"brief":[38],"4-item":[39],"MEQ":[40],"(MEQ-4)":[41],"7-item":[43],"CEQ":[44],"(CEQ-7)":[45],"may":[46],"reduce":[47],"respondent":[48],"burden,":[49],"but":[50],"Japanese":[51,61,125,160,174,195],"versions":[52,62,149,161,175],"have":[53],"not":[54,130,142],"yet":[55],"been":[56],"developed.":[57],"This":[58],"study":[59],"developed":[60],"MEQ-4":[65,72,152,164,178],"CEQ-7.":[67],"METHODS:":[68],"In":[69,170],"translating":[70],"CEQ-7,":[74],"our":[75],"procedures":[76],"were":[77,155,167,181],"informed":[78],"recommendations":[81],"\\"Principles":[84],"Good":[86],"Practice":[87],"for":[88,95,106],"Translation":[90,107],"Cultural":[92,109],"Adaptation":[93],"Process":[94],"Patient-Reported":[96],"Outcomes":[97],"(PRO)":[98],"Measures:":[99],"Report":[100],"ISPOR":[103],"Task":[104],"Force":[105],"Adaptation.\\"":[110],"Separately,":[111],"experts":[112],"reviewed":[115],"semantic":[116],"nuances":[117],"naturalness":[120],"appropriateness":[122],"wording.":[126],"Cognitive":[127],"debriefing":[128],"was":[129,141],"conducted":[131],"because":[132],"recruiting":[133],"an":[134],"appropriate":[135],"Japanese-speaking":[136,210],"sample":[137],"with":[138],"psychedelic":[139],"experience":[140],"feasible.":[143],"RESULTS:":[144],"final,":[146],"approved":[147],"back-translated":[148],"CEQ-7":[154,166,180],"developed,":[156,182],"authorized":[159],"established.":[168],"CONCLUSIONS:":[169],"present":[172],"study,":[173],"enabling":[183],"more":[184],"rapid":[185],"efficient":[187],"assessments":[188],"mystical":[190],"among":[194],"speakers.":[196],"Future":[197],"studies":[198],"should":[199],"evaluate":[200],"their":[201],"comprehensibility,":[202],"interpretability,":[203],"cultural":[204],"appropriateness,":[205],"reliability,":[206],"validity":[208],"samples.":[211]}
Authors
- Futaba Umemura (ORCID: https://orcid.org/0009-0000-6379-4803)
- Hiroko Kotajima‐Murakami
- Justin C. Strickland (ORCID: https://orcid.org/0000-0003-1077-0394)
- Matthew W. Johnson (ORCID: https://orcid.org/0000-0001-7068-0513)
- Kazutaka Ikeda (ORCID: https://orcid.org/0000-0001-8342-0278)
- Albert Garcia‐Romeu (ORCID: https://orcid.org/0000-0003-2182-1644)
Institutions
- University of Maryland, Baltimore (US)
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- Tokyo Metropolitan Institute of Medical Science (JP)
- National Center of Neurology and Psychiatry (JP)
- National Institute of Mental Health (JP)
- Niigata University (JP)
Publication Details
- Journal
- Neuropsychopharmacology Reports
- Published
- 2026-08-27
- DOI
- https://doi.org/10.1002/npr2.70164
- Primary Topic
- Psychedelics and Drug Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tokyo Medical and Dental University
- Japan Society for the Promotion of Science